CORE LABORATORIES INC (CLB) Stock Fundamental Analysis
USA - NYSE:CLB - US21867A1051 - Common Stock
15.595 USD
+0.21 (+1.33%)
Taking everything into account, CLB scores 5 out of 10 in our fundamental rating. CLB was compared to 60 industry peers in the Energy Equipment & Services industry. While CLB has a great health rating, its profitability is only average at the moment. CLB has a expensive valuation and it also scores bad on growth.
1. Profitability
1.1 Basic Checks
In the past year CLB was profitable.
In the past year CLB had a positive cash flow from operations.
CLB had positive earnings in 4 of the past 5 years.
Each year in the past 5 years CLB had a positive operating cash flow.
1.2 Ratios
The Return On Assets of CLB (5.43%) is better than 66.67% of its industry peers.
CLB has a Return On Equity of 11.84%. This is in the better half of the industry: CLB outperforms 68.33% of its industry peers.
With a decent Return On Invested Capital value of 9.29%, CLB is doing good in the industry, outperforming 71.67% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for CLB is in line with the industry average of 7.82%.
The last Return On Invested Capital (9.29%) for CLB is above the 3 year average (8.80%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.43% | ||
| ROE | 11.84% | ||
| ROIC | 9.29% |
ROA(3y)4.98%
ROA(5y)0.23%
ROE(3y)13.12%
ROE(5y)-16.91%
ROIC(3y)8.8%
ROIC(5y)8.69%
1.3 Margins
The Profit Margin of CLB (6.21%) is better than 61.67% of its industry peers.
In the last couple of years the Profit Margin of CLB has declined.
With a Operating Margin value of 11.16%, CLB perfoms like the industry average, outperforming 60.00% of the companies in the same industry.
In the last couple of years the Operating Margin of CLB has declined.
Looking at the Gross Margin, with a value of 19.95%, CLB is doing worse than 70.00% of the companies in the same industry.
CLB's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 11.16% | ||
| PM (TTM) | 6.21% | ||
| GM | 19.95% |
OM growth 3Y7.68%
OM growth 5Y-4.33%
PM growth 3Y12.69%
PM growth 5Y-17.05%
GM growth 3Y-3.24%
GM growth 5Y-5.25%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so CLB is still creating some value.
CLB has about the same amout of shares outstanding than it did 1 year ago.
The number of shares outstanding for CLB has been increased compared to 5 years ago.
The debt/assets ratio for CLB has been reduced compared to a year ago.
2.2 Solvency
An Altman-Z score of 3.23 indicates that CLB is not in any danger for bankruptcy at the moment.
CLB has a better Altman-Z score (3.23) than 81.67% of its industry peers.
CLB has a debt to FCF ratio of 3.32. This is a good value and a sign of high solvency as CLB would need 3.32 years to pay back of all of its debts.
CLB has a Debt to FCF ratio of 3.32. This is in the better half of the industry: CLB outperforms 63.33% of its industry peers.
CLB has a Debt/Equity ratio of 0.42. This is a healthy value indicating a solid balance between debt and equity.
CLB has a Debt to Equity ratio (0.42) which is in line with its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.42 | ||
| Debt/FCF | 3.32 | ||
| Altman-Z | 3.23 |
ROIC/WACC1.06
WACC8.77%
2.3 Liquidity
CLB has a Current Ratio of 2.37. This indicates that CLB is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of CLB (2.37) is better than 70.00% of its industry peers.
CLB has a Quick Ratio of 1.76. This is a normal value and indicates that CLB is financially healthy and should not expect problems in meeting its short term obligations.
CLB's Quick ratio of 1.76 is fine compared to the rest of the industry. CLB outperforms 65.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.37 | ||
| Quick Ratio | 1.76 |
3. Growth
3.1 Past
The earnings per share for CLB have decreased by -9.41% in the last year.
Measured over the past years, CLB shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -13.14% on average per year.
CLB shows a decrease in Revenue. In the last year, the revenue decreased by -1.02%.
CLB shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -4.75% yearly.
EPS 1Y (TTM)-9.41%
EPS 3Y7.42%
EPS 5Y-13.14%
EPS Q2Q%-12%
Revenue 1Y (TTM)-1.02%
Revenue growth 3Y3.66%
Revenue growth 5Y-4.75%
Sales Q2Q%0.09%
3.2 Future
CLB is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 12.78% yearly.
Based on estimates for the next years, CLB will show a small growth in Revenue. The Revenue will grow by 3.47% on average per year.
EPS Next Y-17.36%
EPS Next 2Y-1.48%
EPS Next 3Y-0.94%
EPS Next 5Y12.78%
Revenue Next Year-2.71%
Revenue Next 2Y0.74%
Revenue Next 3Y-1.03%
Revenue Next 5Y3.47%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 20.25, CLB is valued on the expensive side.
Compared to the rest of the industry, the Price/Earnings ratio of CLB is on the same level as its industry peers.
When comparing the Price/Earnings ratio of CLB to the average of the S&P500 Index (25.89), we can say CLB is valued slightly cheaper.
Based on the Price/Forward Earnings ratio of 18.26, the valuation of CLB can be described as rather expensive.
The rest of the industry has a similar Price/Forward Earnings ratio as CLB.
Compared to an average S&P500 Price/Forward Earnings ratio of 34.59, CLB is valued a bit cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 20.25 | ||
| Fwd PE | 18.26 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, CLB is valued expensively inside the industry as 81.67% of the companies are valued cheaper.
The rest of the industry has a similar Price/Free Cash Flow ratio as CLB.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 21.27 | ||
| EV/EBITDA | 11.19 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-1.48%
EPS Next 3Y-0.94%
5. Dividend
5.1 Amount
With a yearly dividend of 0.27%, CLB is not a good candidate for dividend investing.
CLB's Dividend Yield is comparable with the industry average which is at 2.97.
With a Dividend Yield of 0.27, CLB pays less dividend than the S&P500 average, which is at 2.44.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.27% |
5.2 History
The dividend of CLB decreases each year by -55.13%.
CLB has paid a dividend for at least 10 years, which is a reliable track record.
CLB has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)-55.13%
Div Incr Years0
Div Non Decr Years3
5.3 Sustainability
CLB pays out 5.83% of its income as dividend. This is a sustainable payout ratio.
DP5.83%
EPS Next 2Y-1.48%
EPS Next 3Y-0.94%
NYSE:CLB (11/17/2025, 12:05:23 PM)
15.595
+0.21 (+1.33%)
Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryEnergy Equipment & Services
Earnings (Last)
Earnings (Next)
Inst Owners114.84%
Inst Owner Change-3.63%
Ins Owners1.04%
Ins Owner Change0.15%
Market Cap731.25M
Revenue(TTM)517.50M
Net Income(TTM)32.12M
Analysts48
Price Target15.64 (0.29%)
Short Float %13.82%
Short Ratio11.27
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.27% |
Yearly Dividend0.04
Dividend Growth(5Y)-55.13%
DP5.83%
Div Incr Years0
Div Non Decr Years3
Ex-Date
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)6.26%
Min EPS beat(2)-0.33%
Max EPS beat(2)12.86%
EPS beat(4)1
Avg EPS beat(4)1.9%
Min EPS beat(4)-4.67%
Max EPS beat(4)12.86%
EPS beat(8)4
Avg EPS beat(8)4.82%
EPS beat(12)7
Avg EPS beat(12)5.16%
EPS beat(16)8
Avg EPS beat(16)3.39%
Revenue beat(2)2
Avg Revenue beat(2)0.73%
Min Revenue beat(2)0.02%
Max Revenue beat(2)1.44%
Revenue beat(4)2
Avg Revenue beat(4)-0.96%
Min Revenue beat(4)-3.38%
Max Revenue beat(4)1.44%
Revenue beat(8)3
Avg Revenue beat(8)-0.5%
Revenue beat(12)4
Avg Revenue beat(12)-1.2%
Revenue beat(16)5
Avg Revenue beat(16)-1.06%
PT rev (1m)11.51%
PT rev (3m)3.95%
EPS NQ rev (1m)1.83%
EPS NQ rev (3m)-11.89%
EPS NY rev (1m)-4.51%
EPS NY rev (3m)-6.19%
Revenue NQ rev (1m)-0.19%
Revenue NQ rev (3m)-0.66%
Revenue NY rev (1m)0.3%
Revenue NY rev (3m)0.26%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 20.25 | ||
| Fwd PE | 18.26 | ||
| P/S | 1.41 | ||
| P/FCF | 21.27 | ||
| P/OCF | 14.71 | ||
| P/B | 2.69 | ||
| P/tB | 4.43 | ||
| EV/EBITDA | 11.19 |
EPS(TTM)0.77
EY4.94%
EPS(NY)0.85
Fwd EY5.48%
FCF(TTM)0.73
FCFY4.7%
OCF(TTM)1.06
OCFY6.8%
SpS11.04
BVpS5.79
TBVpS3.52
PEG (NY)N/A
PEG (5Y)N/A
Graham Number10.01
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.43% | ||
| ROE | 11.84% | ||
| ROCE | 11.66% | ||
| ROIC | 9.29% | ||
| ROICexc | 9.8% | ||
| ROICexgc | 12.66% | ||
| OM | 11.16% | ||
| PM (TTM) | 6.21% | ||
| GM | 19.95% | ||
| FCFM | 6.64% |
ROA(3y)4.98%
ROA(5y)0.23%
ROE(3y)13.12%
ROE(5y)-16.91%
ROIC(3y)8.8%
ROIC(5y)8.69%
ROICexc(3y)9.11%
ROICexc(5y)8.99%
ROICexgc(3y)11.75%
ROICexgc(5y)11.63%
ROCE(3y)11.03%
ROCE(5y)10.9%
ROICexgc growth 3Y11.32%
ROICexgc growth 5Y-6.37%
ROICexc growth 3Y11.52%
ROICexc growth 5Y-2.86%
OM growth 3Y7.68%
OM growth 5Y-4.33%
PM growth 3Y12.69%
PM growth 5Y-17.05%
GM growth 3Y-3.24%
GM growth 5Y-5.25%
F-Score7
Asset Turnover0.88
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.42 | ||
| Debt/FCF | 3.32 | ||
| Debt/EBITDA | 1.58 | ||
| Cap/Depr | 104.6% | ||
| Cap/Sales | 2.96% | ||
| Interest Coverage | 6.66 | ||
| Cash Conversion | 68.62% | ||
| Profit Quality | 107.03% | ||
| Current Ratio | 2.37 | ||
| Quick Ratio | 1.76 | ||
| Altman-Z | 3.23 |
F-Score7
WACC8.77%
ROIC/WACC1.06
Cap/Depr(3y)71.15%
Cap/Depr(5y)68.67%
Cap/Sales(3y)2.22%
Cap/Sales(5y)2.39%
Profit Quality(3y)84.24%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-9.41%
EPS 3Y7.42%
EPS 5Y-13.14%
EPS Q2Q%-12%
EPS Next Y-17.36%
EPS Next 2Y-1.48%
EPS Next 3Y-0.94%
EPS Next 5Y12.78%
Revenue 1Y (TTM)-1.02%
Revenue growth 3Y3.66%
Revenue growth 5Y-4.75%
Sales Q2Q%0.09%
Revenue Next Year-2.71%
Revenue Next 2Y0.74%
Revenue Next 3Y-1.03%
Revenue Next 5Y3.47%
EBIT growth 1Y-6.83%
EBIT growth 3Y11.62%
EBIT growth 5Y-8.87%
EBIT Next Year8.35%
EBIT Next 3Y4.07%
EBIT Next 5Y17.46%
FCF growth 1Y286.32%
FCF growth 3Y23.36%
FCF growth 5Y-8.39%
OCF growth 1Y165.78%
OCF growth 3Y15.5%
OCF growth 5Y-8.83%
CORE LABORATORIES INC / CLB FAQ
Can you provide the ChartMill fundamental rating for CORE LABORATORIES INC?
ChartMill assigns a fundamental rating of 5 / 10 to CLB.
What is the valuation status for CLB stock?
ChartMill assigns a valuation rating of 2 / 10 to CORE LABORATORIES INC (CLB). This can be considered as Overvalued.
Can you provide the profitability details for CORE LABORATORIES INC?
CORE LABORATORIES INC (CLB) has a profitability rating of 5 / 10.
Can you provide the PE and PB ratios for CLB stock?
The Price/Earnings (PE) ratio for CORE LABORATORIES INC (CLB) is 20.25 and the Price/Book (PB) ratio is 2.69.
Can you provide the financial health for CLB stock?
The financial health rating of CORE LABORATORIES INC (CLB) is 7 / 10.